Cover Image

Safety of synchronous prophylactic ablation of the anterior saphenous vein in patients undergoing great saphenous vein thermal ablation- 6 months follow-up data of the SYNCHRONOUS study

Background - The SYNCHRONOUS-study investigates simultaneous ASV-ablation with great saphenous vein (GSV) treatment in endovenous laser ablation (EVLA) for preventing varicose vein recurrence. This sub-study examines complication rates associated with prophylactic ASV-ablation. - Methods - Among 117...

Full description

Saved in:
Bibliographic Details
Main Authors: Dietrich, Carmen (Author) , Hirsch, Tobias (Author) , Hartmann, Karsten (Author) , Mattausch, Thomas (Author) , Wenzel, Hans-Christian (Author) , Zollmann, Philipp (Author) , Veltman, Jürgen (Author) , Weiler, Thomas K (Author) , Lengfellner, Guido (Author) , Müller, Lars (Author) , Stücker, Markus (Author) , Pannier, Felizitas (Author) , Uhlmann, Lorenz (Author) , Müller-Christmann, Christine (Author)
Format: Article (Journal)
Language:English
Published: 2024
In: Phlebology
Year: 2024, Volume: 39, Issue: 9, Pages: 585-591
ISSN:1758-1125
DOI:10.1177/02683555241257840
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1177/02683555241257840
Get full text
Author Notes:Carmen K Dietrich, Tobias Hirsch, Karsten Hartmann, Thomas Mattausch, Hans-Christian Wenzel, Philipp Zollmann, Jürgen Veltman, Thomas K Weiler, Guido Lengfellner, Lars Müller, Markus Stücker, Felizitas Pannier, Lorenz Uhlmann, Christine Müller-Christmann
Description
Summary:Background - The SYNCHRONOUS-study investigates simultaneous ASV-ablation with great saphenous vein (GSV) treatment in endovenous laser ablation (EVLA) for preventing varicose vein recurrence. This sub-study examines complication rates associated with prophylactic ASV-ablation. - Methods - Among 1173 patients with refluxing GSV, 604 underwent GSV-ablation only, and 569 received additional ASV-ablation. Complication rates were compared over 6 months. - Results - Approximately 80% of patients were complication-free with minor bruising and dysesthesia being most common complications. After 6 months, additional prophylactic ASV-ablation did not increase the rate of complications compared to GSV-only treatment. - Conclusion - The 6-months follow-up data suggests that prophylactic ASV-closure, alongside GSV-treatment, is safe, with similar complication rates to GSV-only EVLA.
Item Description:Online veröffentlicht: 30. Mai 2024
Gesehen am 21.01.2025
Physical Description:Online Resource
ISSN:1758-1125
DOI:10.1177/02683555241257840

Similar Items